Skip to main content

Table 2 Telemonitoring studies with a positive outcome

From: Health technology assessment review: Remote monitoring of vital signs - current status and future challenges

Paper Setting Disease Parameters measured (frequency) Transmission frequency Review frequency Outcome
Breslow 2007 [43, 44] In hospital - ICU Multiple - all critically ill patients Multiple continuously; all measured parameters + video monitoring Continuously Continuously Reduced mortality by up to 33%, number of ventilator days by up to 25%, length of stay by up to 17%
Antonicelli et al. 2008 [30] Community Chronic heart failure (CHF) BP (daily), ECG (weekly), body weight (weekly), 24-h urine output (weekly) Daily Weekly Telecare versus usual care: decreased hospital readmission 9 versus 26 (P < 0.01); trend towards decreased mortality 3 versus 5; total patients 28 versus 29 (N = 57)
Fursse et al. 2008 [29] Community Diabetes, hypertension, CHF Blood glucose (daily), BP (daily), SpO2 (daily) Daily On alerts, regularly - not specified Mean reductions of 11 mmHg systolic and 2 mmHg diastolic in patients with CHF, 0.4% HbA1c in those with diabetes, and 12 mmHg systolic and 2 mmHg diastolic in those with hypertension (no control group; N = 29)
Green et al. 2008 [31] Community Hypertension BP (twice weekly) Twice weekly Fortnightly Higher proportion of patients (after 12 months) whose BP was controlled (< 140/90); telemonitored group 56% versus usual care 31% (80% increase; N = 778)
Kisner et al. 2008 [61] In hospital - ward Atrial fibrillation post CABG SpO2 (continuously) Continuously On alerts Incidence of atrial fibrillation in telemonitored group was 14% versus 26% (prior to telemonitoring; P = 0.016; N = 119; control cohort = 238)
Morguet et al. 2008 [33] Community CHF Weight (daily), BP (daily), pulse rate (daily), ECG (on request) Daily Twice weekly, on alerts 50% reduction in hospital admissions (38 versus 77/100 patient years, P = 0.034), 54% reduction in hospital length of stay (317 versus 693 days/100 patient years; P < 0.0001) (N = 128)
Nakamoto et al. 2008 [63] Community Hypertension: drug trial of temlisartan versus amlodipine BP (twice daily) Twice daily End of study Evening systolic BP reductions higher in telmisartan versus amlodipine group (13 ± 3 versus 6 ± 3 mmHg); non-significant differences in morning BP reduction between both groups; better daytime normalization with telmisartan (N = 40)
Nielsen et al. 2008 [27] Community ICD, pacemaker ECG (continuously) Daily, on alerts On alerts 26% of unplanned clinic visits initiated by telemonitored data (N = 260)
Ricci et al. 2008 [28] Community ICD, pacemaker ECG (continuously) Daily, on alerts Fortnightly, on alerts 37% of patients had changes to their medication, device reprogramming, or were called in for further investigations (N = 117)
Woodend et al. 2008 [34] Community Angina, heart Failure BP (daily), weight (daily), ECG (not specified) Daily Weekly 32% reduction in hospital admission (0.4 versus 0.59 hospital readmission rate per patient, P = 0.048); 46% reduction in length of stay in hospital if readmitted (2.11 versus 3.93 days, P = 0.038) (N = 249)
Parati et al. 2009 [35] Community Hypertension BP (not specified) Not specified On alerts Increased daytime BP normalization (< 130/90), 62% versus 50% (P < 0.05); less frequent treatment changes, 9% versus 14% (P < 0.05) (N = 228)
  1. BP, blood pressure; CABG, coronary artery bypass graft; CHF, chronic heart failure; ECG, electrocardiograph; ICD, implantable cardioverter-defibrillator.